Antidepressant Adult Suicidality Labeling To Be Presented For Advisory Committee Review
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA will present potential labeling changes on antidepressant-related suicidality in adults at Dec. 13 PDAC meeting.
You may also be interested in...
FDA Should Add Age Modification To Antidepressant Suicidality Warning, Committee Says
Current “black box” warning on pediatric suicidality should be expanded to note that risk does not appear to extend beyond young adults, with possible protective effects in elderly populations.
FDA Should Add Age Modification To Antidepressant Suicidality Warning, Committee Says
Current “black box” warning on pediatric suicidality should be expanded to note that risk does not appear to extend beyond young adults, with possible protective effects in elderly populations.
Antidepressant MedGuide Distribution Imminent; Unit-Of-Use Packs To Follow
The new patient Medication Guide is expected to reach pharmacies the week of March 7. The standardized MedGuides will be issued as tear-off pads for about a year until manufacturers implement unit-of-use packaging, which would allow the guide to be pre-packaged with every prescription.